MANF facilitates breast cancer cell survival under glucose-starvation conditions via prkn-mediated mitophagy regulation.
Zhenchong XiongLin YangChao ZhangWeiling HuangWenjing ZhongJiarong YiJikun FengXiazi ZouxuLibing SongXi WangPublished in: Autophagy (2024)
During tumor expansion, breast cancer (BC) cells often experience reactive oxygen species accumulation and mitochondrial damage because of glucose shortage. However, the mechanism by which BC cells deal with the glucose-shortage-induced oxidative stress remains unclear. Here, we showed that MANF (mesencephalic astrocyte derived neurotrophic factor)-mediated mitophagy facilitates BC cell survival under glucose-starvation conditions. MANF-mediated mitophagy also promotes fatty acid oxidation in glucose-starved BC cells. Moreover, during glucose starvation, SENP1-mediated de-SUMOylation of MANF increases cytoplasmic MANF expression through the inhibition of MANF's nuclear translocation and hence renders mitochondrial distribution of MANF. MANF mediates mitophagy by binding to PRKN (parkin RBR E3 ubiquitin protein ligase), a key mitophagy regulator, in the mitochondria. Under conditions of glucose starvation, protein oxidation inhibits PRKN activity; nevertheless, the CXXC motif of MANF alleviates protein oxidation in RING II-domain of PRKN and restores its E3 ligase activity. Furthermore, MANF-PRKN interactions are essential for BC tumor growth and metastasis. High MANF expression predicts poor outcomes in patients with BC. Our results highlight the prosurvival role of MANF-mediated mitophagy in BC cells during glucose starvation, suggesting MANF as a potential therapeutic target.
Keyphrases
- induced apoptosis
- blood glucose
- cell cycle arrest
- oxidative stress
- reactive oxygen species
- hydrogen peroxide
- poor prognosis
- binding protein
- fatty acid
- signaling pathway
- endoplasmic reticulum stress
- transcription factor
- small molecule
- protein protein
- blood pressure
- type diabetes
- metabolic syndrome
- cell proliferation
- adipose tissue
- pi k akt
- risk assessment
- mouse model
- nitric oxide